Literature DB >> 17464566

Molecular profiling in breast cancer.

Shannon R Morris1, Lisa A Carey.   

Abstract

Molecular profiling has provided biological evidence for the heterogeneity of breast cancer through the identification of intrinsic subtypes like Luminal A, Luminal B, HER2+/ER- and basal-like. It has also led to the development of clinically applicable gene expression-based prognostic panels like the Mammaprint and Oncotype Dx. The increasingly sophisticated understanding allowed by this and similar technology promises future individualized therapy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17464566     DOI： 10.1007/s11154-007-9035-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


  77 in total

1.  Outcome signature genes in breast cancer: is there a unique set?

Authors:  Liat Ein-Dor; Itai Kela; Gad Getz; David Givol; Eytan Domany
Journal:  Bioinformatics       Date:  2004-08-12       Impact factor: 6.937

2.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Authors:  François Bertucci; Pascal Finetti; Jacques Rougemont; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Carole Tarpin; Catherine Nguyen; Luc Xerri; Rémi Houlgatte; Jocelyne Jacquemier; Patrice Viens; Daniel Birnbaum
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

5.  High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.

Authors:  Daniel E Stange; Bernhard Radlwimmer; Falk Schubert; Frank Traub; Andreas Pich; Grischa Toedt; Frank Mendrzyk; Ulrich Lehmann; Roland Eils; Hans Kreipe; Peter Lichter
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Authors:  Donald A Berry; Constance Cirrincione; I Craig Henderson; Marc L Citron; Daniel R Budman; Lori J Goldstein; Silvana Martino; Edith A Perez; Hyman B Muss; Larry Norton; Clifford Hudis; Eric P Winer
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

7.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

Authors:  Howard Y Chang; Dimitry S A Nuyten; Julie B Sneddon; Trevor Hastie; Robert Tibshirani; Therese Sørlie; Hongyue Dai; Yudong D He; Laura J van't Veer; Harry Bartelink; Matt van de Rijn; Patrick O Brown; Marc J van de Vijver
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

8.  Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Authors:  François Bertucci; Pascal Finetti; Nathalie Cervera; Emmanuelle Charafe-Jauffret; Emilie Mamessier; José Adélaïde; Stéphane Debono; Gilles Houvenaeghel; Dominique Maraninchi; Patrice Viens; Colette Charpin; Jocelyne Jacquemier; Daniel Birnbaum
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

9.  A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines.

Authors:  D T Ross; C M Perou
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

10.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029
View more
  16 in total

1.  Fusion RNA profiling provides hints on cell of origin of mysterious tumor.

Authors:  Zhongqiu Xie; Hui Li
Journal:  Mol Cell Oncol       Date:  2016-11-29

2.  The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.

Authors:  Brianna J Klein; Lianhua Piao; Yuanxin Xi; Hector Rincon-Arano; Scott B Rothbart; Danni Peng; Hong Wen; Connie Larson; Xi Zhang; Xia Zheng; Michael A Cortazar; Pedro V Peña; Anthony Mangan; David L Bentley; Brian D Strahl; Mark Groudine; Wei Li; Xiaobing Shi; Tatiana G Kutateladze
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

Review 3.  Gene expression profiling of breast cancer.

Authors:  Ting Bao; Nancy E Davidson
Journal:  Adv Surg       Date:  2008

4.  Metformin induces a senescence-associated gene signature in breast cancer cells.

Authors:  Christopher C Williams; Brittany A Singleton; Shawn D Llopis; Elena V Skripnikova
Journal:  J Health Care Poor Underserved       Date:  2013-02

5.  Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).

Authors:  Mei Hong Zhang; Hong Tao Man; Xiao Dan Zhao; Ni Dong; Shi Liang Ma
Journal:  Biomed Rep       Date:  2013-10-25

6.  Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.

Authors:  Patrick C O Leary; Sarah A Penny; Roisin T Dolan; Catherine M Kelly; Stephen F Madden; Elton Rexhepaj; Donal J Brennan; Amanda H McCann; Fredrik Pontén; Mathias Uhlén; Radoslaw Zagozdzon; Michael J Duffy; Malcolm R Kell; Karin Jirström; William M Gallagher
Journal:  BMC Cancer       Date:  2013-04-02       Impact factor: 4.430

7.  Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.

Authors:  David A Wiese; Tuddow Thaiwong; Vilma Yuzbasiyan-Gurkan; Matti Kiupel
Journal:  BMC Cancer       Date:  2013-09-03       Impact factor: 4.430

8.  Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors.

Authors:  Pia Boström; Mirva Söderström; Tuire Palokangas; Tero Vahlberg; Yrjö Collan; Olli Carpen; Pirkko Hirsimäki
Journal:  BMC Res Notes       Date:  2009-07-17

9.  Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer.

Authors:  Zsuzsanna Varga; Peter Sinn; Florian Fritzsche; Arthur von Hochstetter; Aurelia Noske; Peter Schraml; Christoph Tausch; Andreas Trojan; Holger Moch
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Portraits of breast cancer progression.

Authors:  Gul S Dalgin; Gabriela Alexe; Daniel Scanfeld; Pablo Tamayo; Jill P Mesirov; Shridar Ganesan; Charles DeLisi; Gyan Bhanot
Journal:  BMC Bioinformatics       Date:  2007-08-06       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.